Top

The European Journal of Health Economics

Published in:

Open Access 01-09-2020 | Vaccination | Editorial

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

Authors: Sebastian Neumann-Böhme, Nirosha Elsem Varghese, Iryna Sabat, Pedro Pita Barros, Werner Brouwer, Job van Exel, Jonas Schreyögg, Tom Stargardt

Published in: The European Journal of Health Economics | Issue 7/2020

Excerpt

While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect against the disease COVID-19, policymakers should prepare for the next challenge: uptake of the vaccine among the public. Having a vaccine does not automatically imply it will be used. Compliance with the anti-H1N1 vaccine during the 2009 influenza pandemic, for instance, was low [1], and in the decade since, vaccination rates have remained an issue of concern [2] while vaccination hesitancy has become more prevalent, leading to increases in disease outbreaks in multiple countries [3]. It is, therefore, important to understand whether or not people are willing to be vaccinated against COVID-19, as this can have large consequences for the success a vaccination programme—with potentially large health and economic consequences. In this editorial, we provide some first insights into this willingness to be vaccinated, based on a multi-country European study [4], which hopefully result in more attention for this important issue. …

Blasi, F., Aliberti, S., Mantero, M., Centanni, S.: Compliance with anti-H1N1 vaccine among healthcare workers and general population. Clin. Microbiol. Infect. 18, 37–41 (2012). https://doi.org/10.1111/j.1469-0691.2012.03941.xCrossRefPubMed

Kata, A.: Anti-vaccine activists, Web 2.0, and the postmodern paradigm—an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine. 30, 3778–3789 (2012). https://doi.org/10.1016/j.vaccine.2011.11.112CrossRefPubMed

Larson H, de Figueiredo A, Karafillakis E, Rawal M.: State of Vaccine Confidence in the EU 2018. Luxembourg: Publications Office of the European Union. 2018. https://doi.org/10.2875/241099

Countering COVID-19: A European survey on acceptability and commitment to preventive measures. 2020 [cited 26 Apr 2020]. https://www.hche.uni-hamburg.de/en/forschung/corona.html. Accessed 26 Apr 2020

World Health Organization: Draft of the landscape of COVID-19 candidate vaccines. World Heal Organ. 2020; 4. https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1. Accessed 26 Apr 2020

Callaway BE.: The race for coronavirus vaccines. In: Nature [Internet]. 2020 [cited 1 May 2020]. https://www.nature.com/articles/d41586-020-01221-y. Accessed 1 May 2020

Welcome trust.: How can we develop a COVID-19 vaccine quickly? In: Welcome Explainer [Internet]. 2020. https://wellcome.ac.uk/news/how-can-we-develop-covid-19-vaccine-quickly. Accessed 30 Apr 2020

Tundzhay B.: Covid-19 vaccine availability unrealistic in 12-18 month period. In: Pharma Technology Focus [Internet]. 2020 [cited 26 Apr 2020] pp. 1–6. https://www.pharmaceutical-technology.com/comment/covid-19-vaccine-availability/. Accessed 26 Apr 2020

Fine, P., Eames, K., Heymann, D.L.: “Herd immunity”: a rough guide. Clin. Infect. Dis. 52, 911–916 (2011). https://doi.org/10.1093/cid/cir007CrossRefPubMed

10.

Gypsyamber B, Dowdy D.: What is Herd Immunity and How Can We Achieve It With COVID-19 ? In: Johns Hopkins Bloomberg School of Public Health Expert Insights [Internet]. 2020 [cited 26 Apr 2020] pp. 1–5. https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html. Accessed 26 Apr 2020

11.

Andre, F.E., Booy, R., Bock, H.L., Clemens, J., Datta, S.K., John, T.J., et al.: Policy and practice Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull. World Health Organ. 040089, 140–146 (2008). https://doi.org/10.2471/BLT.07.040089CrossRef

12.

Siciliani, L., Wild, C., McKee, M., Kringos, D., Barry, M.M., Barros, P.P., et al.: Strengthening Vaccination programmes and health systems in the European Union: a framework for action. Health Policy (New York). (2020). https://doi.org/10.1016/j.healthpol.2020.02.015CrossRef

13.

Betsch, C., Böhm, R., Korn, L.: Inviting free-riders or appealing to prosocial behavior? Game-theoretical reflections on communicating herd immunity in vaccine advocacy. Health Psychol. 32, 978–985 (2013). https://doi.org/10.1037/a0031590CrossRefPubMed

14.

Korn, L., Betsch, C., Böhm, R., Meier, N.W.: Social nudging: the effect of social feedback interventions on vaccine uptake. Health Psychol. 37, 1045–1054 (2018). https://doi.org/10.1037/hea0000668CrossRefPubMed

15.

VCP. The State of Vaccine Confidence 2015. 2015. https://www.vaccineconfidence.org/s/VCP_The-State-of-Vaccine-Confidence_2015.pdf. Accessed 28 Apr 2020

16.

Jiang, S.: Don’t rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. Nature 579, 321 (2020). https://doi.org/10.1038/d41586-020-00751-9CrossRefPubMed

17.

Thomson, A., Watson, M.: Listen, understand, engage. Sci. Transl. Med. 4, 138ed6 (2012). https://doi.org/10.1126/scitranslmed.3004264CrossRefPubMed

18.

Can the world find a good covid-19 vaccine quickly enough ? The Economist. Apr 2020: 1–14. https://www.economist.com/briefing/2020/04/16/can-the-world-find-a-good-covid-19-vaccine-quickly-enough. Accessed 13 May 2020

19.

Robert Horsburgh, C. Jr., Mahon, B.E.: Infectious disease epidemiology. In: Rothman, K.J., Greenland, S., Lash, T.L. (eds.) Modern Epidemiology, 3rd edn. Wolters Kluwer Health, Lippincott Williams & Wilkins (2008). https://www.ovid.com/product-details.4634.html

20.

Nishiura H, Chowell G. The Effective reproduction number as a prelude to statistical estimation of time-dependent epidemic trends BT—Mathematical and Statistical Estimation Approaches in Epidemiology. In: Chowell, G., Hyman, J.M., Bettencourt, L.M.A., Castillo-Chavez, C., (eds.), pp. 103–121. Springer Netherlands, Dordrecht (2009). https://doi.org/10.1007/978-90-481-2313-1_5

21.

Flaxman S, Mishra S, Gandy A, Unwin HJT, Coupland H, Mellan TA, et al. Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in European countries: technical description update. arXiv Prepr arXiv200411342. 2020. https://doi.org/10.25561/77731

22.

Pitzer, V.E., Chitwood, M., Havumaki, J., Menzies, N.A., Warren, J.L., Weinberger, D.M., et al.: The impact of changes in diagnostic testing practices on estimates of COVID-19 transmission in the United States. medRxiv (2020). https://doi.org/10.1101/2020.04.20.20073338CrossRefPubMedPubMedCentral

23.

Gomes AMGM, Corder RM, King JG, Langwig KE, Souto-maior C, Carneiro J, et al.: Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold. 2020. https://www.medrxiv.org/content/10.1101/2020.04.27.20081893v3.full.pdf. Accessed 4 June 2020

24.

WHO. Measles.: fighting a global resurgence. 2019 [cited 8 May 2020] pp. 1–7. https://www.who.int/news-room/feature-stories/detail/measles-fighting-a-global-resurgence. Accessed 8 May 2020

25.

Böhm, R., Meier, N.W., Groß, M., Korn, L., Betsch, C.: The willingness to vaccinate increases when vaccination protects others who have low responsibility for not being vaccinated. J. Behav. Med. 42, 381–391 (2019). https://doi.org/10.1007/s10865-018-9985-9CrossRefPubMed

26.

Barclay, V.C., Smieszek, T., He, J., Cao, G., Rainey, J.J., Gao, H., et al.: Positive network assortatively of influenza vaccination at a high school: implications for outbreak risk and herd immunity. PLoS One. (2014). https://doi.org/10.1371/journal.pone.0087042CrossRefPubMedPubMedCentral

27.

Van Den Hof, S., Meffre, C.M.A., Conyn-van Spaendonck, M.A.E., Woonink, F., De Melker, H.E., Van Binnendijk, R.S.: Measles outbreak in a community with very low vaccine coverage, The Netherlands. Emerg. Infect. Dis. 7, 593–597 (2001). https://doi.org/10.3201/eid0707.017743CrossRefPubMedPubMedCentral

28.

Centers for Disease Control and Prevention.: Measles Cases and Outbreaks. 2020 [cited 1 May 2020]. Available: https://www.cdc.gov/measles/cases-outbreaks.html. Accessed 1 May 2020

29.

Meier, N.W., Böhm, R., Korn, L., Betsch, C.: Individual preferences for voluntary vs. mandatory vaccination policies: an experimental analysis. Eur. J. Public Health. 30, 50–55 (2019). https://doi.org/10.1093/eurpub/ckz181CrossRef

Title: Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
Authors: Sebastian Neumann-Böhme
Nirosha Elsem Varghese
Iryna Sabat
Pedro Pita Barros
Werner Brouwer
Job van Exel
Jonas Schreyögg
Tom Stargardt
Publication date: 01-09-2020
Publisher: Springer Berlin Heidelberg
Keywords: Vaccination
COVID-19
Published in: The European Journal of Health Economics / Issue 7/2020
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-020-01208-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2020

Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)

Patterns of care and cost profiles of women with breast cancer in Italy: EPICOST study based on real world data

An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values

Quantifying the economic impact of caregiving for Duchenne muscular dystrophy (DMD) in Spain